UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 8, 2007
CONSECO, INC.
 (Exact name of registrant as specified in its charter)

   Delaware                               001-31792               75-3108137
----------------------                 ----------------        --------------
(State or other                          (Commission          (I.R.S. Employer
jurisdiction of                          File Number)        Identification No.)
organization)

11825 North Pennsylvania Street
        Carmel, Indiana                                             46032
--------------------------------------                            ----------
(Address of principal executive offices)                          (Zip Code)	

(317) 817-6100
 (Registrant's telephone number, including area code)

Not Applicable
 (Former name or former address,
if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  
Item 1.01. Entry into a Material Definitive Agreement.
On May 8, 2007, three insurance companies (Conseco Insurance Company, Conseco Life Insurance Company and Washington National Insurance Company) in the Conseco Insurance Group unit of Conseco, Inc. (the "Company"), entered into agreements under which those insurance companies will coinsure, with an effective date of January 1, 2007, most of their older inforce equity-indexed annuity and fixed annuity business with Reassure America Life Insurance Company ("REALIC"), a subsidiary of Swiss Re Life & Health America Inc.
In the transaction, REALIC will pay a ceding commission of approximately $76.5 million, 100% coinsure and administer these policies, and recognize policy profits as they emerge over time. The Conseco companies will transfer to REALIC approximately $3.0 billion of statutory policy and other reserves, as well as the assets backing these policies. The transaction, which is subject to insurance regulatory approval in several states, is expected to close prior to December 31, 2007.
Conseco expects to record after-tax charges related to the transaction of approximately $65 million, plus the block's earnings between the effective date and the close of the transaction. We recognized $8.7 million of these charges in the first quarter of 2007, related to impairment losses on the assets expected to be transferred to REALIC at closing that were in an unrealized loss position at March 31, 2007. The remaining charge, resulting principally from unrecovered insurance intangibles, is expected to be recorded when the transaction closes. The block's after-tax earnings for the first quarter of 2007 were approximately $10 million. A copy of the Company's press release is attached hereto as Exhibit 99.1.
 
Item 2.02. Results of Operations and Financial Condition.
On May 8, 2007, the Company issued: (i) a press release announcing its financial results for the quarter ended March 31, 2007, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference; and
(ii) additional financial information related to the Company's financial and operating results for the quarter ended March 31, 2007, a copy of which is attached hereto as Exhibit 99.3 and is incorporated herein by reference.
The information contained under Item 2.02 in this Current Report on Form 8-K (including Exhibits 99.2 and 99.3) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
 
Item 9.01(d). Financial Statements and Exhibits.
The following materials are furnished as exhibits to this Current Report on Form 8-K:
99.1 Press release dated May 8, 2007 related to coinsurance agreements.
99.2 Press release dated May 8, 2007 related to financial results for the quarter ended March 31, 2007.
99.3 First Quarter 2007 Financial and Operating Results for the period ended March 31, 2007.
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
CONSECO, INC.
May 9, 2007

By:  /s/ John R. Kline
     ------------------------
     John R. Kline
       Senior Vice President and
       Chief Accounting Officer	

Exhibit 99.1
NEWS
For Release Immediate
Contacts (News Media) Tony Zehnder, Corporate Communications 312.396.7086
(Investors) Daniel Murphy, Investor Relations 317.817.2893
Conseco to divest old block of fixed and equity-indexed annuities
Carmel, Ind., May 8, 2007 - Conseco, Inc. (NYSE: CNO), today announced agreements under which three insurance companies in its Conseco Insurance Group unit will coinsure, with an effective date of Jan. 1, 2007, most of their older inforce equity-indexed annuity and fixed annuity business with Reassure America Life Insurance Company ("REALIC"), a subsidiary of Swiss Re Life & Health America Inc.
Conseco CEO Jim Prieur said, "This transaction is an important step in improving the performance of the company. It will allow us to retire four annuity administrative systems, which will further simplify our back office and reduce our operating expenses. We will consider how best to apply the proceeds from the transaction and the $175 million of capital currently held to support these policies to increase Conseco's return on equity. Options under consideration include repurchases of Conseco common stock and investments in the business."
In the transaction, REALIC will pay a ceding commission of approximately $76.5 million, 100% coinsure and administer these policies, and recognize policy profits as they emerge over time. The Conseco companies will transfer to REALIC approximately $3.0 billion of statutory policy and other reserves, as well as the assets backing these policies. The transaction, which is subject to insurance regulatory approval in several states, is expected to close prior to yearend.
Most of the policies involved in the transaction were issued in the 1980s and 1990s by companies that were later acquired by Conseco. Approximately 90% of the policies being coinsured are from Conseco Insurance Company; the remainder are from Conseco Life Insurance Company and Washington National Insurance Company.
Conseco expects to record after-tax charges related to the transaction of approximately $65 million, plus the block's earnings between the effective date and the close of the transaction. We recognized $8.7 million of these charges in the first quarter of 2007, related to impairment losses on the assets expected to be transferred to REALIC at closing that were in an unrealized loss position at March 31, 2007. The remaining charge, resulting principally from unrecovered insurance intangibles, is expected to be recorded when the transaction closes. The block's after-tax earnings for the first quarter of 2007 were approximately $10 million.
Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's web site at www.conseco.com.
-more-
Conseco (2) May 8, 2007
Cautionary Statement Regarding Forward-Looking Statements. Our statements, trend analyses and other information contained in this press release relative to markets for Conseco's products and trends in Conseco's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things: (i) our ability to obtain adequate and timely rate increases on our supplemental health products including our long-term care business; (ii) mortality, morbidity, usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products; (iii) changes in our assumptions related to the cost of policies produced or the value of policies inforce at the Effective Date; (iv) our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (v) performance of our investments; (vi) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (vii) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (viii) our ability to remediate the material weakness in internal controls over the actuarial reporting process that we identified at year-end 2006 and to maintain effective controls over financial reporting; (ix) our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives; (x) our ability to achieve an upgrade of the financial strength ratings of our insurance company subsidiaries as well as the potential impact of rating downgrades on our business; (xi) the risk factors or uncertainties listed from time to time in our filings with the Securities and Exchange Commission; (xii) regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends to us, regulation of financial services affecting (among other things) bank sales and underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; (xiii) general economic conditions and other factors, including prevailing interest rate levels, stock and credit market performance and health care inflation, which may affect (among other things) our ability to sell products and access capital on acceptable terms, the returns on and the market value of our investments, and the lapse rate and profitability of policies; and (xiv) changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products.
Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected. All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.
- # # # # -
 
Exhibit 99.2
NEWS
For Release Immediate
Contacts (News Media) Tony Zehnder, Corporate Communications 312.396.7086
(Investors) Daniel Murphy, Investor Relations 317.817.2893
Conseco Reports First Quarter Results
Carmel, Ind., May 8, 2007 - Conseco, Inc. (NYSE: CNO) today reported results for the first quarter of 2007.
"Although results for the quarter are below expectations, Conseco is making tangible progress across the organization," CEO Jim Prieur said regarding the first quarter results. "Sales growth was very strong in both our Bankers Life and Colonial Penn businesses, and the sales mix at Conseco Insurance Group has improved. We experienced reduced losses in our other business in run-off segment, where we are beginning to see the anticipated improvements in claims management as well as the positive impact from the re-rate program. As we have reported previously, improvement in the performance of that block is expected to occur over several quarters."
"We continue to take significant steps to improve Conseco's financial return," Prieur said. "As described in our separate release today, we reached a definitive agreement to sell, through a 100% coinsurance agreement, a block of fixed and equity-indexed annuities that were not generating an acceptable return on equity (ROE). Our Board has also approved an increase in the stock buyback program, from $150 million to $350 million and we will continue to move on opportunities to improve ROE going forward."
First quarter 2007 results:
o Net operating income (1): $14.6 million, compared to $55.8 million in 1Q06
o Net operating income per diluted share: 10 cents, compared to 36 cents in 1Q06
o Net income applicable to common stock: $.9 million, compared to $55.1 million in 1Q06 (including $13.7 million of net realized investment losses in 1Q07 vs. $.7 million of net realized investment losses in 1Q06)
o Net income per diluted share: 1 cent, compared to 35 cents in 1Q06 (including 9 cents of net realized investment losses in 1Q07 vs. 1 cent of net realized investment losses in 1Q06)
o Earnings before net realized investment losses, corporate interest and taxes ("EBIT") (2): $53.3 million, compared to $114.6 million in 1Q06
o Sales (3): $134.2 million, up 10% from 1Q06 (includes sales from Medicare Advantage Plans through our partnership with Coventry Health Care (Coventry))
Financial strength at March 31, 2007:
o Book value per common share, excluding accumulated other comprehensive income (loss) (4), was $27.17, compared to $27.06 at December 31, 2006
o Book value per diluted share, excluding accumulated other comprehensive income (loss) (4), was $25.24, compared to $25.64 at December 31, 2006
o Debt-to-total capital ratio, excluding accumulated other comprehensive income (loss) (4), was 17.3% at both March 31, 2007 and December 31, 2006
- more -
 
Conseco (2) May 8, 2007
Operating results
Our segments reflect the addition of Colonial Penn as a separate segment. All prior period segment disclosures have been restated to conform to our new presentation.
Results by segment for the quarter were as follows ($ in millions, except per share data):

                                                                                              Three Months Ended
                                                                                                   March 31,
                                                                                          --------------------------
                                                                                          2007                  2006
                                                                                          ----                  ----
EBIT (2):
  Bankers Life....................................................................       $ 42.8                $ 57.2
  Conseco Insurance Group.........................................................         51.5                  41.9
  Colonial Penn...................................................................          4.6                   5.1
  Other Business in Run-off.......................................................        (30.9)                 24.0
  Corporate Operations, excluding corporate interest expense......................        (14.7)                (13.6)
                                                                                         ------                ------

     EBIT.........................................................................         53.3                 114.6

Corporate interest expense........................................................        (16.1)                (12.4)
                                                                                         ------                ------

       Income before net realized investment losses and taxes.....................         37.2                 102.2

Tax expense.......................................................................         13.1                  36.9
                                                                                         ------                ------

     Net income before net realized investment losses.............................         24.1                  65.3
Preferred stock dividends:
   5.50% Class B mandatorily convertible preferred stock..........................          9.5                   9.5
                                                                                         ------                ------

     Net operating income.........................................................         14.6                  55.8

Net realized investment losses, net of related amortization and taxes.............        (13.7)                  (.7)
                                                                                         ------                ------

     Net income applicable to common stock........................................       $   .9                $ 55.1
                                                                                         ======                ======

Per diluted share:
     Net operating income.........................................................       $  .10                $  .36

     Net realized investment losses, net of related amortization and taxes........         (.09)                 (.01)
                                                                                         ------                ------

     Net income applicable to common stock........................................       $  .01                $  .35
                                                                                         ======                ======	

In our Bankers Life segment, pre-tax operating earnings were $42.8 million in the first quarter of 2007, compared to $57.2 million in the first quarter of 2006. The decline in earnings is due to: (a) higher amortization of Medicare supplement insurance intangibles of $15.5 million resulting from increased lapses, principally attributable to customers switching to Medicare Advantage Plans, (including a small number of exchanges into the Medicare Advantage (MA) products we distribute through our partnership with Coventry); partially offset by $5.6 million improvement in margins on Medicare supplement due to higher revenue and improved loss ratios and (b) higher amortization of long-term care insurance intangibles of $4.1 million due to changes in assumptions for future rate increases. Results in the current period also reflect the seasonality impact of prescription drug program (PDP) and Medicare Advantage policy benefit patterns that produced breakeven results for the quarter but are expected to produce lower benefits and higher margins in subsequent quarters.
In our Conseco Insurance Group segment, pre-tax operating earnings were $51.5 million in the first quarter of 2007, compared to $41.9 million in the first quarter of 2006. Results for the current period reflect: (a) a decline in life insurance margin of approximately $10.0 million due to higher mortality; (b) an increase of $6.5 million to the reserve for the R-factor litigation matter tentatively settled in 2006; and (c) a release of reserves for return of premium benefits on certain specified disease policies of $19.3 million resulting from the inaccurate coding discovered in the process of remediating data control weaknesses reported last quarter. Results for the first quarter of 2006 include charges of $8.8 million related to the R-factor litigation.
-more-
Conseco (3) May 8, 2007
Our Colonial Penn segment achieved pre-tax operating earnings of $4.6 million in the first quarter of 2007, compared to $5.1 million in the first quarter of 2006.
In our Other Business in Run-off segment, we recognized a pre-tax operating loss of $30.9 million in the first quarter of 2007, compared to earnings of $24.0 million in the first quarter of 2006. Results for the current period include claim reserve strengthening of $22.0 million resulting from changes in reserving methodology for a relatively small block of business (Transport Life) with a high concentration of policies with lifetime benefits and inflation riders. Results for the 2006 period include several adjustments to insurance liabilities that increased earnings by $14 million.
The Corporate Operations segment includes our investment advisory subsidiary and corporate expenses, including interest on corporate debt. Results for the current quarter include a charge of $4.0 million related to a legacy bankruptcy related litigation matter and an increase of $6.5 million to the reserve for the R-factor litigation matter tentatively settled in 2006. Results for the 2006 period included $8.9 million of costs related to the proposed litigation settlement.
Net realized losses of $13.7 million in 1Q07 included $8.7 million of impairment losses on those assets expected to be transferred at the closing of the aforementioned coinsurance agreement that were in an unrealized loss position at March 31, 2007.
Sales results
In addition to the sales of traditional products, Bankers Life, through a partnership with Coventry, distributes risk-share Medicare PDP and private-fee-for-service plan (PFFS) through their career agents.
At Bankers Life (career distribution), total sales in 1Q07 were a record $102.8 million, up 15% over 1Q06, reflecting strong growth in our life product line and PFFS sales through our partnership with Coventry. Partly offsetting these gains were lower annuity and medicare supplement sales.
At Conseco Insurance Group (independent distribution), total sales, including sales of PDP through Coventry, in 1Q07 were $21.0 million, down 13% from 1Q06 reflecting lower sales of PDP and Medicare Supplement, partly offset by higher sales of annuities and specified disease. Excluding PDP, CIG's sales rose 2% over 1Q06.
At Colonial Penn (direct distribution), total 1Q07 sales were $10.4 million, up 24% over 1Q06 as we continued the investment in our marketing efforts.
-more-
Conseco (4) May 8, 2007
Conference Call
The company will host a conference call to discuss results at 10:00 a.m. Eastern Daylight Time on May 9, 2007. The webcast can be accessed through the Investors section of the company's website as follows: http://investor.conseco.com. Listeners should go to the website at least 15 minutes before the event to register and download any necessary audio software. During the call, we will be referring to a presentation that will be available Wednesday morning through the investors section of the company's website.
About Conseco
Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's web site at www.conseco.com.

(1) Management believes that an analysis of Net Income applicable to common stock before net realized investment gains or losses, net of related amortization and income taxes, ("Net Operating Income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because realized investment gains or losses can be affected by events that are unrelated to the company's underlying fundamentals. A reconciliation of Net Operating Income to Net Income applicable to common stock is provided in the table on page 2.
(2) Management believes that an analysis of earnings before net realized investment gains (losses), corporate interest and taxes ("EBIT," a non-GAAP financial measure) provides a clearer comparison of the operating results of the company quarter-over-quarter because it excludes: (i) corporate interest expense; and (ii) net realized investment gains (losses) that are unrelated to the company's underlying fundamentals. A reconciliation of EBIT to Net Income applicable to common stock is provided in the table on page 2.
(3) Measured by new annualized premium, which Includes 6% of annuity and 10% of single premium whole life deposits and 100% of all other premiums.
(4) The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. The corresponding GAAP measures for debt-to-total capital and book value per common share were 17.5% and $26.89, respectively, at March 31, 2007, and 17.5% and $26.58, respectively, at December 31, 2006.
-more-
Conseco (5) May 8, 2007
Cautionary Statement Regarding Forward-Looking Statements. Our statements, trend analyses and other information contained in this press release relative to markets for Conseco's products and trends in Conseco's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things: (i) our ability to obtain adequate and timely rate increases on our supplemental health products including our long-term care business; (ii) mortality, morbidity, usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products; (iii) changes in our assumptions related to the cost of policies produced or the value of policies inforce at the Effective Date; (iv) our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (v) performance of our investments; (vi) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (vii) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (viii) our ability to remediate the material weakness in internal controls over the actuarial reporting process that we identified at year-end 2006 and to maintain effective controls over financial reporting; (ix) our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives; (x) our ability to achieve an upgrade of the financial strength ratings of our insurance company subsidiaries as well as the potential impact of rating downgrades on our business; (xi) the risk factors or uncertainties listed from time to time in our filings with the Securities and Exchange Commission; (xii) regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends to us, regulation of financial services affecting (among other things) bank sales and underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; (xiii) general economic conditions and other factors, including prevailing interest rate levels, stock and credit market performance and health care inflation, which may affect (among other things) our ability to sell products and access capital on acceptable terms, the returns on and the market value of our investments, and the lapse rate and profitability of policies; and (xiv) changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products.
Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected. All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.
- Tables Follow -
 
Conseco (6) May 8, 2007
CONSECO, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
 (Dollars in millions)

                                                                                              March 31,        December 31,
                                                                                                2007               2006
                                                                                                ----               ----
                                                                                             (unaudited)
ASSETS
Investments:
     Actively managed fixed maturities at fair value (amortized cost:
       March 31, 2007 - $23,256.9; December 31, 2006 - $22,946.9).........................    $23,182.8         $22,802.9
     Equity securities at fair value (cost: March 31, 2007 - $28.5;
       December 31, 2006 - $23.9).........................................................         29.7              24.8
     Mortgage loans.......................................................................      1,665.0           1,642.2
     Policy loans.........................................................................        409.3             412.5
     Trading securities...................................................................        823.2             675.2
     Other invested assets ...............................................................        174.6             178.8
                                                                                              ---------         ---------
       Total investments..................................................................     26,284.6          25,736.4

Cash and cash equivalents:
     Unrestricted.........................................................................        271.8             385.9
     Restricted...........................................................................         21.5              24.0
Accrued investment income.................................................................        356.4             344.5
Value of policies inforce at the Effective Date...........................................      2,044.3           2,137.2
Cost of policies produced.................................................................      1,182.2           1,106.7
Reinsurance receivables...................................................................        860.5             850.8
Income tax assets, net....................................................................      1,772.1           1,786.9
Assets held in separate accounts..........................................................         28.7              28.9
Other assets..............................................................................        332.1             316.0
                                                                                              ---------         ---------

       Total assets.......................................................................    $33,154.2         $32,717.3
                                                                                              =========         =========

LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
     Liabilities for insurance products:
       Interest-sensitive products........................................................    $13,044.1         $13,018.0
       Traditional products...............................................................     12,175.1          12,094.1
       Claims payable and other policyholder funds........................................        848.0             832.3
       Liabilities related to separate accounts...........................................         28.7              28.9
     Other liabilities....................................................................        687.3             611.8
     Investment borrowings................................................................        647.7             418.3
     Notes payable - direct corporate obligations.........................................        999.3           1,000.8
                                                                                              ---------        ----------

         Total liabilities................................................................     28,430.2          28,004.2
                                                                                              ---------        ----------

Commitments and Contingencies

Shareholders' equity:
     Preferred stock......................................................................        667.8             667.8
     Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued
       and outstanding: March 31, 2007 - 150,845,158; December 31, 2006 - 152,165,108)....          1.5               1.5
     Additional paid-in capital...........................................................      3,455.1           3,473.2
     Accumulated other comprehensive loss.................................................        (41.8)            (72.6)
     Retained earnings....................................................................        641.4             643.2
                                                                                              ---------         ---------

       Total shareholders' equity.........................................................      4,724.0           4,713.1
                                                                                              ---------         ---------

       Total liabilities and shareholders' equity.........................................    $33,154.2         $32,717.3
                                                                                              =========         =========	

- more -
 
Conseco (7) May 8, 2007
CONSECO, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS
 (Dollars in millions, except per share data)

                                                                     Three months ended
                                                                          March 31,
                                                                    --------------------
                                                                    2007            2006
                                                                    ----            ----
Revenues:
Insurance policy income.....................................      $  762.8       $  754.7
Net investment income:
     General account assets.................................         377.9          351.3
     Policyholder and reinsurer accounts and other
        special-purpose portfolios..........................           4.9           14.1
Net realized investment losses..............................         (34.9)          (3.1)
Fee revenue and other income................................           3.8            4.7
                                                                  --------       --------

       Total revenues.......................................       1,114.5        1,121.7
                                                                  --------       --------

Benefits and expenses:
Insurance policy benefits...................................         801.3          726.8
Interest expense............................................          23.6           16.4
Amortization................................................         116.2          118.6
Costs related to the proposed litigation settlement.........          13.0           17.7
Other operating costs and expenses..........................         144.2          141.1
                                                                  --------       --------

       Total benefits and expenses..........................       1,098.3        1,020.6
                                                                  --------       --------

       Income before income taxes...........................          16.2          101.1

Income tax expense on period income.........................           5.8           36.5
                                                                  --------       --------

       Net income...........................................          10.4           64.6

Preferred stock dividends...................................           9.5            9.5
                                                                  --------       --------

       Net income applicable to common stock................      $     .9       $   55.1
                                                                  ========       ========

Earnings per common share:
   Basic:
     Weighted average shares outstanding....................   150,936,000    151,521,000
                                                               ===========    ===========

     Net income                                                $       .01    $       .36
                                                               ===========    ===========

   Diluted:
     Weighted average shares outstanding....................   151,067,000    183,541,000
                                                               ===========    ===========

     Net income.............................................   $       .01    $       .35
                                                               ===========    ===========	

- more -
 
Conseco (8) May 8, 2007
CONSECO, INC. AND SUBSIDIARIES
COLLECTED PREMIUMS
 (Dollars in millions)

                                                                                                   Three months ended
                                                                                                        March 31,
                                                                                                  2007             2006
                                                                                                  ----             ----
Bankers Life segment:
  Annuity...............................................................................         $212.2            $233.4
  Supplemental health...................................................................          373.4             322.9
  Life..................................................................................           48.1              43.2
                                                                                                 ------            ------
  Total collected premiums..............................................................         $633.7            $599.5
                                                                                                 ======            ======
Conseco Insurance Group segment:
  Annuity...............................................................................         $120.1            $ 36.2
  Supplemental health...................................................................          154.2             159.6
  Life..................................................................................           77.2              84.1
                                                                                                 ------            -------
  Total collected premiums..............................................................         $351.5            $279.9
                                                                                                 ======            ======
Colonial Penn segment:
  Life..................................................................................         $ 26.7            $ 23.4
  Supplemental health...................................................................            2.6               3.0
                                                                                                 ------            ------
  Total collected premiums..............................................................         $ 29.3            $ 26.4
                                                                                                 ======            ======
Other Business in Run-off segment:
  Long-term care........................................................................         $ 80.6            $ 87.3
  Major medical.........................................................................             .6               1.1
                                                                                                 ------            ------
  Total collected premiums..............................................................         $ 81.2            $ 88.4
                                                                                                 ======            ======	

BENEFIT RATIOS ON MAJOR SUPPLEMENTAL HEALTH LINES OF BUSINESS

                                                                                                   Three Months Ended
                                                                                                        March 31,
                                                                                                -----------------------
                                                                                                2007               2006
                                                                                                ----               ----
Bankers Life segment:
Medicare Supplement:
  Earned premium........................................................................    $174 million     $165 million
  Benefit ratio(a)......................................................................           66.6%            68.1%
Long-Term Care:
  Earned premium........................................................................    $153 million     $143 million
  Benefit ratio(a)......................................................................          104.3%            96.5%
  Interest-adjusted benefit ratio (a non-GAAP measure)(b)...............................           73.8%            66.9%
Conseco Insurance Group (CIG) segment:
Medicare Supplement:
  Earned premium........................................................................     $60 million      $68 million
  Benefit ratio(a)......................................................................           66.9%            60.3%
Specified Disease:
  Earned premium........................................................................     $90 million      $90 million
  Benefit ratio(a)......................................................................           53.2%            77.5%
  Interest-adjusted benefit ratio (a non-GAAP measure)(b)...............................           20.4%            45.9%
Other Business in Run-off segment:
  Earned premium........................................................................     $80 million      $89 million
  Benefit ratio(a)......................................................................          163.5%            94.8%
  Interest-adjusted benefit ratio (a non-GAAP measure)(b)...............................          105.3%            45.1%

-------------------------------------------------------------------------------------
(a)  The benefit ratio is calculated by dividing the related product's insurance
     policy benefits by insurance policy income.
(b)  The interest-adjusted benefit ratio (a non-GAAP measure) is calculated by
     dividing the product's insurance policy benefits less interest income on
     the accumulated assets backing the insurance liabilities by insurance
     policy income. Interest income is an important factor in measuring the
     performance of longer duration health products. The net cash flows
     generally cause an accumulation of amounts in the early years of a policy
     (accounted for as reserve increases), which will be paid out as benefits in
     later policy years (accounted for as reserve decreases). Accordingly, as
     the policies age, the benefit ratio will typically increase, but the
     increase in the change in reserve will be partially offset by interest
     income earned on the accumulated assets. The interest-adjusted benefit
     ratio reflects the interest income offset. Since interest income is an
     important factor in measuring the performance of these products, management
     believes a benefit ratio, which includes the effect of interest income, is
     useful in analyzing product performance.	

- # # # # -

First Quarter 2007
Financial and Operating Results
For the period ended March 31, 2007
Conseco, Inc.

Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements.   Our statements, trend analyses and other information contained in these
materials relative to markets for Conseco’s products and trends in Conseco’s operations or financial results, as well as other statements, contain
forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995.  Forward-
looking statements typically are identified by the use of terms such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “project,” “intend,”
“may,” “will,” “would,” “contemplate,” “possible,” “attempt,” “seek,” “should,” “could,” “goal,” “target,” “on track,” “comfortable with,” “optimistic” and
similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words
carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results
of operations, financial position, and our business outlook or they state other ‘‘forward-looking’’ information based on currently available
information. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-
looking statements include, among other things:  (i) our ability to obtain adequate and timely rate increases on our supplemental health products
including our long-term care business; (ii) mortality, morbidity, usage of health care services, persistency, the adequacy of our previous reserve
estimates and other factors which may affect the profitability of our insurance products; (iii) changes in our assumptions related to the cost of
policies produced or the value of policies inforce at the Effective Date; (iv) our ability to achieve anticipated expense reductions and levels of
operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (v)
performance of our investments; (vi) our ability to identify products and markets in which we can compete effectively against competitors with
greater market share, higher ratings, greater financial resources and stronger brand recognition; (vii) the ultimate outcome of lawsuits filed
against us and other legal and regulatory proceedings to which we are subject; (viii) our ability to remediate the material weakness in internal
controls over the actuarial reporting process that we identified at year-end 2006 and to maintain effective controls over financial reporting; (ix)
our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution
channels and marketing initiatives; (x) our ability to achieve an upgrade of the financial strength ratings of our insurance company subsidiaries
as well as the potential impact of rating downgrades on our business; (xi) the risk factors or uncertainties listed from time to time in our filings
with the Securities and Exchange Commission; (xii) regulatory changes or actions, including those relating to regulation of the financial affairs of
our insurance  companies, such as the payment of dividends to us, regulation of financial services affecting (among other things) bank sales and
underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health
insurance products; (xiii) general economic conditions and other factors, including prevailing interest rate levels, stock and credit market
performance and health care inflation, which may affect (among other things) our ability to sell products and access capital on acceptable terms,
the returns on and the market value of our investments, and the lapse rate and profitability of policies; and (xiv) changes in the Federal income
tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products. Other factors and assumptions not
identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ
materially from those projected. All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the
foregoing cautionary statement.  Our forward-looking statements speak only as of the date made.  We assume no obligation to update or to
publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments,
changes in assumptions or changes in other factors affecting the forward-looking statements.
2

Non-GAAP Measures
This presentation contains the following financial measures that differ from the comparable measures
under Generally Accepted Accounting Principles (GAAP):  operating earnings measures; book value
excluding accumulated other comprehensive income (loss) per diluted share; operating return measures;
earnings before net realized investment gains (losses) and corporate interest and taxes; debt to capital
ratios, excluding accumulated other comprehensive income (loss); and interest-adjusted benefit ratios.  
Reconciliations between those non-GAAP measures and the comparable GAAP measures are included
in the Appendix, or on the page such measure is presented.
While management believes these measures are useful to enhance understanding and comparability of
our financial results, these non-GAAP measures should not be considered substitutes for the most
directly comparable GAAP measures.
3

Progress in executing plan
Strong sales growth at Bankers and Colonial Penn, better sales mix at CIG
On plan with Run-off LTC in improving claims management and in re-rates
Announcement of sale of $3 billion block of Fixed and EIA annuities
Board approval of increase in stock buyback program to $350 million
$30 million repurchased to date
Quarterly results
Earnings from Core Businesses down principally due to higher mortality
costs in CIG and higher lapse rates of Med Supp at Bankers
Continued volatility in Run-off LTC earnings, with claims reserve
strengthening of $22.0 million
Q1 2007 Summary
CNO
4

New Business
Volumes (NAP)
CNO Consolidated
(in millions)
Record quarterly sales for
BLC
Strong growth in sales for
CP, stronger growth in leads
CIG sales mix improvement
New business volumes are measured by new annualized premium, which includes 6% of annuity premiums, 10%
of single-premium whole life deposits, and 100% of all other premiums.  Includes prescription drug sales (PDP)
and private-fee-for-service (PFFS) sales.
Q1 2006
$122.3
Q2 2006
$98.3
Q3 2006
$92.6
Q4 2006
$87.8
Q1 2007
$134.2
Col. Penn
Bankers
CIG
Trailing 4 Quarters NAP:                                                    $374.9                 $390.4              $403.0               $401.0            $412.9
5

Collected
Premium Growth
CNO Consolidated
($ millions)
$994.2
CIG*
Bankers*
Run-Off
Collected premium on core
businesses increased 12%
from the same quarter in the
prior year
Collected premium is up 13%
from the four quarters ending
on March 31, 2007 versus the
comparable period in the prior
year
Colonial Penn*
$1,095.7
$4,067.4
$3,958.7
$3,897.8
$3,706.6
$3,606.3
Tr. 4 Qtrs. Col. Prem.-Core Businesses*:
Q1 2007
Q4 2006
Q3 2006
Q2 2006
Q1 2006
6

Operating ROE
CNO
Operating ROE*, Trailing 4 Quarters
Operating ROE (excl. Q2 2006 charge)**,
Trailing 4 Quarters
*Operating return excludes net realized
investment gains (losses).  Equity excludes
accumulated other comprehensive income
(loss) and the value of net operating loss
carryforwards, and assumes conversion of
preferred stock.  See Appendix for
corresponding GAAP measure.
**Operating return, as calculated and defined
on the left side of this page, but before Q2 2006
charge related to the tentative litigation
settlement.  See Appendix for corresponding
GAAP measure.
Conseco has set a long-term goal of improving its Operating ROE –
after-tax earnings divided by equity (excluding our NOL deferred tax
asset from equity and other adjustments below) – to 11% in 2009
7

Q1 Earnings
CNO Consolidated
*Management believes that an analysis of earnings before net realized investment gains (losses) and corporate
interest and taxes (“EBIT,” a non-GAAP financial measure) provides an alternative measure to compare the
operating results of the company quarter-over-quarter because it excludes: (1) corporate interest expense; and
(2) net realized gains (losses) that are unrelated to the company’s underlying fundamentals. The chart above
provides a reconciliation of EBIT to net income applicable to common stock.
Q1 2006
Q1 2007
Bankers Life
$57.2
$42.8
Conseco Insurance Group
41.9
51.5
Colonial Penn
5.1
4.6
Other Business in Run-Off
24.0
(30.9)
Corporate operations, excluding interest expense
(13.6)
(14.7)
    Total EBIT*
114.6
53.3
Corporate interest expense
(12.4)
(16.1)
    Income before net realized investment losses and taxes
102.2
37.2
Tax expense
36.9
13.1
    Net income before net realized losses
65.3
24.1
Preferred stock dividends
9.5
9.5
    Net operating income
55.8
14.6
Net realized investment losses, net of related amortization and taxes
(0.7)
(13.7)
    Net income applicable to common stock
$55.1
$0.9
8
($ millions)

Operating EPS (Diluted)
CNO
Operating EPS, Before Q2 2006 Charge**
**Operating earnings per share, before Q2 2006
charge related to the tentative litigation settlement.
See Appendix for corresponding GAAP measure.
Operating EPS*
*Operating earnings per share exclude net
realized investment gains (losses). See Appendix
for corresponding GAAP measure.
9

Q1 Earnings
LTC Closed Block
Q1 2006
Q1 2007
Insurance policy income
$88.9
$79.5
Net investment income
44.7
47.0
Fee revenue and other income
0.1
0.1
    Total revenues
133.7
126.6
Insurance policy benefits
84.3
130.0
Amortization related to operations
3.5
5.7
Other operating costs and expenses
21.9
21.8
    Total benefits and expenses
109.7
157.5
    Income (loss) before net realized investment gains (losses) and income taxes
$24.0
($30.9)
10
Management believes that an analysis of income (loss) before net realized investment gains (losses), net of
related amortization (a non-GAAP financial measure), is important to evaluate the financial performance of our
business, and is a measure commonly used in the life insurance industry.  Management uses this measure to
evaluate performance because realized gains or losses can be affected by events that are unrelated to a
company’s underlying fundamentals. The chart on Page 8 reconciles the non-GAAP measure to the
corresponding GAAP measure.  See Appendix for a reconciliation of the return on equity measure to the
corresponding GAAP measure.
($ millions)

Segment
Performance
LTC Closed Block
*Operating earnings exclude net realized gains (losses).  See Appendix for corresponding GAAP measure of
our consolidated results of operations.    
Results adversely affected by:
$22.0 million claim reserve
strengthening in Transport block of
business
Claims on larger American Travellers
block developed as expected
Reduced volume of initial claims
contributed to improvement from Q4
2006
PTOI-Trailing 4 Quarters:                  $79.7                $62.7                 $33.3              ($41.9)           ($96.8)
Revenues-Quarterly:                           $133.7              $126.8              $128.1             $127.9            $126.6
Pre-Tax Operating Income*
Revenues -Tr. 4 Quarters:              $536.1             $528.1             $519.6             $516.5            $509.4
($ millions)   
Collected Premiums-Quarterly:     $88.4               $82.4                $80.4                $76.6                 $81.2
11

Interest-Adjusted
Benefit Ratio*
Loss ratio improved vs. prior
quarter
Excluding $22 million of claim
reserve strengthening in
Transport block, Q1 2007
interest-adjusted benefit ratio
was 77.6%
Trailing 4 Quarter Avg.:       48.4%              52.1%            60.1%            83.2%             99.0%
Qtrly. non-int. adjusted:       94.8%             118.0%         136.0%         198.2%       163.5%
LTC Closed Block
*We calculate interest-adjusted benefit ratios by dividing insurance policy benefits less interest income on
the accumulated assets backing the insurance liabilities by insurance policy income.
12

Program for improvement gaining traction
Premium re-rates
Claims management
Technology
Q1 2007 Summary
LTC Closed Block
13

Premium Re-rates
LTC Closed Block
14

Claims management
Improved claim processes resulting in more accurate payments
consistent with policy language, and better customer experience
Closing of Florida case management operation, effective by end
of Q2 2007, to save $1.5 million in expenses per year
Claim appeal and claim review panels strengthening ongoing
compliance process
Continuing to retain industry-leading LTC experts to improve
processes
Program for
Improvement
LTC Closed Block
15

Technology
Improved policy/benefit repository and accumulator tool on track
for mid-2007 implementation
Implemented tool for streamlining manually-intensive policy
administration processes
Approaching completion of strategic LTC system selection
process
Program for
Improvement
LTC Closed Block
16

Financial results affected by experience and related claim
reserve strengthening on subset of block
However, progress on key initiatives:
Achieved re-rate filing goal in $35 million program
Improved claims management processes gaining traction
Progress on systems tools
Segment Summary
LTC Closed Block
17

Book value per diluted share
$25.24 at 3/31/07 vs $24.56 a year earlier and $25.64 at YE 2006
Debt to total capital ratio
17.3% at 3/31/07 vs 15.2% a year earlier and 17.3% at YE 2006
Consolidated RBC ratio
342% at 3/31/07 vs 348% a year earlier and 357% at YE 2006
Net investment income
$376.8 million in Q1 2007 vs $350.3 million in Q1 2006
Earned yield of 5.83% in Q1 2007 vs 5.64% a year earlier
Investment quality
93% of bonds investment grade at 3/31/07 vs 93% at 12/31/06 and 95% at
3/31/06
Essentially no exposure to subprime market
Financial Indicators*
CNO
*See appendix for detail on these indicators, including notes describing non-GAAP measures.
18

Aggregate Interest-Adjusted
Health Benefit Ratio*
CNO
Reduction in Benefit ratio due to
$19.3 million adjustment in
Specified Disease return of
premium reserves
Aggregate Health Benefit Ratio – By Quarter
Core (BLC, CIG & CP) Business
*We calculate interest-adjusted benefit ratios by dividing insurance policy benefits, less interest income on the
accumulated assets backing the insurance liabilities, by insurance policy income.
Aggregate Health Benefit Ratio – By Quarter
Run-Off Business
19

Expenses
CNO
($ millions)
Gross Operating Expenses*, Trailing 4 Quarters
*Gross operating expenses before capitalization of cost of policies produced, capitalization of software
development costs and other adjustments.  Costs related to the tentative litigation settlement are not included in
our gross operating expenses.  This measure is used by the Company to evaluate its progress in reducing gross
operating expenses.
Operating expenses remain
relatively flat despite increases
in collected premium
Back-office consolidation on
track to produce annual cost
savings of $25 million beginning
in 2008
Q1 2007 reflects litigation
settlement and higher marketing
and sales expenses
20

Record sales of $102.8 million
Sales driven by new sales of private-fee-for-service through our partnership
with Coventry
Lower earnings driven by:
Higher amortization of Medicare Supplement insurance intangibles, partially
offset by improvements in margin due to higher revenue and improved loss
ratio
Reduction in long-term care margins due to higher amortization of
insurance intangibles due to changes in assumptions for future rate
increases
Q1 2007 Summary
Bankers
21

Q1 Earnings
Bankers
Q1 2006
Q1 2007
Insurance policy income
$383.0
$412.0
Net investment income
123.5
140.9
Fee revenue and other income
1.4
1.2
    Total revenues
507.9
554.1
Insurance policy benefits
312.7
345.9
Amounts added to policyholder account balances
44.3
47.1
Amortization related to operations
57.4
81.4
Other operating costs and expenses
36.3
36.9
    Total benefits and expenses
450.7
511.3
    Income before net realized investment losses, net of
      related amortization and income taxes
$57.2
$42.8
22
Management believes that an analysis of income (loss) before net realized investment gains (losses), net of
related amortization (a non-GAAP financial measure), is important to evaluate the financial performance of our
business, and is a measure commonly used in the life insurance industry.  Management uses this measure to
evaluate performance because realized gains or losses can be affected by events that are unrelated to a
company’s underlying fundamentals. The chart on Page 8 reconciles the non-GAAP measure to the
corresponding GAAP measure.  See Appendix for a reconciliation of the return on equity measure to the
corresponding GAAP measure.
Q1 2007 Return on Equity (before realized investment gains/(losses): 5.9%
($ millions)

Segment Performance
Bankers
*Operating earnings exclude net realized gains (losses).  See Appendix for corresponding GAAP measure of
our consolidated results of operations.    
2007 decrease driven by:
Higher Med Supp amortization due to
higher lapses in Q1, partially offset by
improvements in margin due to higher
revenue and improved benefit ratios
Higher amortization of LTC intangibles
due to changes in assumptions for
future rate increases
PTOI-Trailing 4 Quarters:                $238.9             $239.4              $252.8            $258.4            $244.0
Revenues-Quarterly:                           $507.9              $509.0              $525.9             $534.3            $554.1
Pre-Tax Operating Income*
Revenues -Tr. 4 Quarters:            $1,922.3        $1,970.3        $2,019.8        $2,077.1     $2,123.3
($ millions)   
23

Benefit Ratio* –
Medicare Supplement
Bankers
Continued favorable claim
experience contributed to
improving benefit ratio
Trailing four quarter benefit
ratio has shown steady
improvement from Q1 2006
Trailing 4 Quarter Avg.:       70.7%              69.6%            68.1%              66.8%           66.4%
*We calculate benefit ratios by dividing insurance policy benefits by insurance policy income.
24

Q1 2007 sales were $46.8 million
Most of sales were to enrollees who previously had no policy with Bankers
Has delivered a chance to cross-sell into new households
Has also helped agent recruiting
PFFS
Bankers
25

Interest-Adjusted Benefit Ratio* –
Long Term Care
Bankers
*We calculate interest-adjusted benefit ratios by dividing insurance policy benefits less interest income on
the accumulated assets backing the insurance liabilities by insurance policy income.
Q1 2007 benefit ratio improved
from prior quarter, but higher
than Q1 2006 due to:
Increased claim activity, higher
persistency and lower new
business volume
Trailing 4 Quarter Avg.:       65.8%              66.4%            67.4%            69.9%             71.6%
Qtrly. non-int. adjusted:       96.5%              96.2%            98.2%           106.7%        104.3%
26

Earnings up 23% vs Q1 2006
Primarily driven by release of return of premium reserves on certain
specified disease policies, partially offset by decline in life insurance margin
and increase in reserve for R-factor matter tentatively settled in 2006
Sales down 13% from Q1 2006 (up 2% excluding PDP)
Strong sales gains in annuities and specified disease partly offset
decreases in Medicare Supplement and PDP
Recently signed agreement with largest distributor of Medicare Supplement
Increased resources in worksite sales to expand distribution of specified
disease products
Q1 2007 Summary
CIG
27

Q1 Earnings
CIG
Management believes that an analysis of income (loss) before net realized investment gains (losses), net of
related amortization (a non-GAAP financial measure), is important to evaluate the financial performance of our
business, and is a measure commonly used in the life insurance industry.  Management uses this measure to
evaluate performance because realized gains or losses can be affected by events that are unrelated to a
company’s underlying fundamentals. The chart on Page 8 reconciles the non-GAAP measure to the
corresponding GAAP measure.  See Appendix for a reconciliation of the return on equity measure to the
corresponding GAAP measure.
Q1 2006
Q1 2007
Insurance policy income
$256.4
$242.0
Net investment income
182.0
175.4
Fee revenue and other income
0.4
0.2
    Total revenues
438.8
417.6
Insurance policy benefits
195.9
185.4
Amounts added to policyholder account balances
66.5
67.0
Amortization related to operations
55.5
38.2
Other operating costs and expenses
79.0
75.5
    Total benefits and expenses
396.9
366.1
    Income before net realized investment gains (losses), net of
      related amortization and income taxes
$41.9
$51.5
28
Q1 2007 Return on Equity (before realized investment gains/(losses): 5.9%
($ millions)

Segment Performance
CIG
*Operating earnings exclude net realized gains (losses). Q2 2006 excludes tentative litigation settlement.  
See Appendix for corresponding GAAP measure of our consolidated results of operations.
Q1 2007 includes:
Adverse life claim experience
Specified disease margins (excluding the $19.3
million release of return of premium reserve)
continued to improve
Lower supplemental health amortization due to better
persistency
Expenses totaling $6.5 million related to certain
litigation reserves
Q1 2006 includes:
Expenses totaling $8.8 million related to certain
litigation reserves
PTOI-Trailing 4 Quarters:                      $234.2              $232.8             $224.2             $189.0           $198.4
Revenues-Quarterly:                                 $438.8               $408.6             $436.0              $445.7           $417.6
Pre-Tax Operating Income*
Revenues-Tr. 4 Quarters:                   $1,772.0          $1,736.6        $1,714.8        $1,729.1     $1,707.9
($ millions)  
29

Benefit Ratio* –
Medicare Supplement
CIG
Benefit ratios in Q1 and Q2
2006 benefited from release of
policy benefit reserves related
to increase in policyholder
lapses
Persistency has improved
Trailing 4 Quarter Avg.:       60.8%              59.3%            60.6%            61.9%             63.6%
*We calculate benefit ratios by dividing insurance policy benefits by insurance policy income.
30

Interest-Adjusted Benefit Ratio* –
Specified Disease
CIG
Q1 2007 reflected paid claims
as expected
Persistency has improved
$19.3 million release of return
of premium reserve
Trailing 4 Quarter Avg.:       45.4%            46.7%              45.9%            47.0%             40.6%
Qtrly. non-int. adjusted:       77.5%            79.9%              73.6%            84.9%             53.2%
*We calculate interest-adjusted benefit ratios by dividing insurance policy benefits, less interest income on
the accumulated assets backing the insurance liabilities, by insurance policy income.
31

Q1 Earnings
Colonial Penn
Q1 2006
Q1 2007
Insurance policy income
$26.4
$29.3
Net investment income
9.7
9.5
Fee revenue and other income
0.1
0.2
    Total revenues
36.2
39.0
Insurance policy benefits
22.8
25.6
Amounts added to policyholder account balances
0.3
0.3
Amortization related to operations
4.2
4.8
Other operating costs and expenses
3.8
3.7
    Total benefits and expenses
31.1
34.4
    Income before net realized investment losses and income taxes
$5.1
$4.6
32
Management believes that an analysis of income (loss) before net realized investment gains (losses), net of
related amortization (a non-GAAP financial measure), is important to evaluate the financial performance of our
business, and is a measure commonly used in the life insurance industry.  Management uses this measure to
evaluate performance because realized gains or losses can be affected by events that are unrelated to a
company’s underlying fundamentals. The chart on Page 8 reconciles the non-GAAP measure to the
corresponding GAAP measure.  See Appendix for a reconciliation of the return on equity measure to the
corresponding GAAP measure.
Q1 2007 Return on Equity (before realized investment gains/(losses): 8.7%
($ millions)

Segment Performance
Colonial Penn
*Operating earnings exclude net realized gains (losses).  See Appendix for corresponding GAAP measure of
our consolidated results of operations.    
Q1 07 sales up 24% vs Q1 06
Strong growth in lead
development
Solid growth in re-activation
campaigns
Continued stable earnings
PTOI-Trailing 4 Quarters:                  $19.0                $20.3                 $19.5                $21.6                $21.1
Revenues-Quarterly:                             $36.2                 $34.9                 $38.4                $41.4                $39.0
Pre-Tax Operating Income*
Revenues -Tr. 4 Quarters:              $143.4             $145.9             $147.9             $150.9            $153.7
($ millions)   
33

Sale of Older CIG Annuity Block:
Transaction Summary
100% coinsurance agreement
134,000 policies, 77% of CIG deferred annuity account value
Policies sold in ’80s and ’90s
Relatively low ROE due to number of admin systems and
inefficient expense structure
Transaction eliminates four admin systems entirely, and all
annuities from two other systems
Expected to close in 2007
Requires approvals from Illinois, Indiana, California, Texas
and Wisconsin
34

Sale of Older CIG Annuity Block:
Financial Impact
Ceding commission of approximately $76.5 million plus capital
backing block of $175 million available to enhance Conseco’s
return on equity:
Repurchase of Conseco common stock
Invest in other high-ROE products and businesses
GAAP carrying value in excess of ceding commission will
generate an after-tax GAAP loss of approximately $65 million,
plus the block’s earnings between the effective date and the
close of the transaction
We realized $8.7 million of these charges in Q1 2007, related to
impairment losses on assets that are expected to be
transferred at closing and are in an unrealized loss position at
March 31, 2007
35

CNO Summary
Steady growth in core businesses
Improvements in earnings run-rate by yearend:
$40 million due to better LTC claims management
$35 million in re-rates
$25 million in operational efficiencies
Increase in share buyback program
Performance shares align interests of shareholders and
management
Payment on 60% of performance shares based on 2007-2009 total
return to shareholders vs peer group
Payment on 40% of performance shares based on 2009 operating return
on equity vs target of 11%
36

Questions and Answers

Appendix

Premiums –
Medicare Supplement/PDP/PFFS
Bankers
(in millions)
Strong sales driven by
PFFS
Q1 2006
$30.8
Q2 2006
$56.6
Q3 2006
$44.0
Q4 2006
$43.1
Q1 2007
$45.3
PDP
Med Supp
PFFS
Medicare Supplement  – First-Year Premiums
Med. Supp. First-Year Prems.-Tr. 4 Qtrs:                 $81.2                $88.1               $93.1                $97.8               $106.7
Med. Supp. Total Premiums-Quarterly:                     $168.5            $156.7            $146.7              $157.2            $178.5
Med. Supp. NAP-Quarterly:                                                 $20.7                    $18.4              $15.3                $18.4                 $14.7
Med. Supp. NAP-Trailing 4 Quarters:                           $75.3                 $76.7              $76.2                 $72.8                $66.8
$11.5
$4.3
$0.5
$0.7
$8.2
$32.8
PDP NAP-Quarterly:
$46.8
-
-
-
-
PFFS NAP-Quarterly:
39

Premiums –
Long-Term Care
Bankers
($ millions)    
Steady decline in first-year
premiums over the past five
quarters
New sales are meeting our
return objectives
First-Year Prems.-Tr. 4 Qtrs:          $62.5               $58.5                 $54.6                $51.2              $48.6
Total Premiums-Quarterly:              $145.7             $151.5             $145.0             $150.2           $158.2
Long-Term Care  – First-Year Premiums
NAP-Quarterly:                                          $11.4                  $12.7                 $12.5                $11.0               $11.7
NAP-Trailing 4 Quarters:                   $57.1                 $52.5                $50.4                $47.6               $47.9
40

Premiums –
Life Insurance
Bankers
($ millions)
Growth driven by:
Continued focus on new agent
training
Expanded advanced life
insurance training for veteran
agents
Q1 2007 NAP up 17% vs. Q1
2006
First-Year Prems.-Tr. 4 Qtrs:                $84.2                $88.4                $90.4                 $90.3              $91.0
Total Premiums-Quarterly:                     $43.2                 $46.6                $47.8                 $46.6              $48.1
Life – First-Year Premiums
NAP-Quarterly:                                               $10.9                    $11.1                 $12.9              $11.4                $12.7
NAP-Trailing 4 Quarters:                         $42.9                  $42.8                $44.7              $46.3                $48.1
41

Premiums –
Annuity
Bankers
($ millions)    
Trailing four quarters first-
year premiums up slightly
from comparable prior-year
period
First-Year Prems.-Tr. 4 Qtrs:              $960.5           $960.1           $1,010.7          $994.6            $973.5
Total Premiums-Quarterly:                   $233.4            $238.3             $278.2             $247.6            $212.2
Annuity – First-Year Premiums
42

Premiums -
Medicare Supplement
CIG
($ millions)
Decline in sales expected to
turn around with new
national distribution
agreement
First-Year Prems.-Tr. 4 Qtrs:      $21.0               $25.6                $28.0               $30.6                $28.9
Total Premiums-Quarterly:           $65.9                $61.9                $54.6              $61.8                $59.8
Medicare Supplement  – First-Year Premiums
NAP-Quarterly:                                      $10.5                   $9.0                    $6.2                  $6.4                   $4.9
NAP-Trailing 4 Quarters:               $29.5                $34.3                 $33.9              $32.1                $26.5
43

Premiums –
Specified Disease
CIG
($ millions)
Sales continue to gain
momentum from refocus of
PMA and introduction of new
Cancer Secure product
26% increase in NAP vs Q1
2006
First-Year Prems.-Tr. 4 Qtrs:          $29.7              $28.8               $28.4                 $28.1              $28.2
Total Premiums-Quarterly:               $91.4              $88.8                $88.1                 $89.4              $92.1
Specified Disease  – First-Year Premiums
NAP-Quarterly:                                           $6.2                    $7.3                    $7.7                    $8.6                 $7.8
NAP-Trailing 4 Quarters:                   $29.5               $27.9                $28.5                $29.8               $31.4
44

Premiums –
Life Insurance
CIG
($ millions)    
In process of rebuilding life
portfolio with new indexed UL
products being introduced in
late 2007
Worksite beginning to contribute
to life sales
First-Year Prems.-Tr. 4 Qtrs:           $7.1                   $6.7                 $6.7                    $6.7                   $6.2
Total Premiums-Quarterly:               $84.1                $78.3              $78.3                 $73.9                $77.2
Life – First-Year Premiums
NAP-Quarterly:                                           $1.7                    $1.1                    $1.0                    $1.8                   $0.9
NAP-Trailing 4 Quarters:                     $6.5                  $6.5                   $6.0                    $5.6                   $4.8
45

Premiums –
Annuity
CIG
($ millions)
268% increase in first-year
premiums vs Q1 2006
Significant contribution from
our national partners and
TSA business
First-Year Prems.-Tr. 4 Qtrs:        $153.3             $218.6           $358.1             $415.5            $500.2
Total Premiums-Quarterly:               $36.2                $92.4             $182.8             $121.9             $120.1
Annuity – First-Year Premiums
46

Premiums –
Life Insurance
Colonial Penn
($ millions)
Growth driven by:
Expanded lead generation
Refocused attention to national
cable segment
Refreshed commercials
Natural growth in direct mail
programs
First-Year Prems.-Tr. 4 Qtrs:          $20.2               $21.2                 $22.0                $22.9              $24.1
Total Premiums-Quarterly:               $23.4                $21.6                 $25.4                $26.8              $26.7
Life – First-Year Premiums
NAP-Quarterly:                                             $8.4                    $9.1                    $8.3                    $7.5                $10.4
NAP-Trailing 4 Quarters:                     $30.4               $32.2                $33.0                $33.3               $35.3
47

Information Related to Certain Non-GAAP Financial Measures
The following provides additional information regarding certain non-GAAP measures used in this presentation.  While management believes these
measures are useful to enhance understanding and comparability of our financial results, these non-GAAP measures should not be considered as
substitutes for the most directly comparable GAAP measures.  Also refer to our latest Form 10-K and Form 10-Q for information concerning non-
GAAP measures.
Operating earnings measures 
Management believes that an analysis of net income applicable to common stock before net realized gains or losses (“net operating income”, a
non-GAAP financial measure) is important to evaluate the performance of the Company and is a key measure commonly used in the life insurance
industry.  Management uses this measure to evaluate performance because realized investment gains or losses can be affected by events that
are unrelated to the Company’s underlying fundamentals.  
In addition, our results for Q2 2006 were affected by an unusual and significant charge related to a tentative litigation settlement.  Management
does not believe that a similar charge is likely to recur within two years, and there were no similar charges recognized within the prior two years.  
Management believes an analysis of operating earnings before this charge is important to evaluate the performance of the Company prior to the
effect of this unusual and significant charge.  
48

Book Value Per Diluted Share *
CNO
*Book value excludes accumulated other comprehensive income (loss). Shares outstanding assumes:
(1) conversion of convertible securities; and (2) the exercise of outstanding stock options and vesting of restricted
stock (each calculated using the treasury stock method). See Appendix for corresponding GAAP measure.
Decrease from Q4 2006
primarily due to additional
shares included for
mandatorily convertible
preferred stock
49

CNO
Debt to Total Capital Ratio *
Level of debt remains flat
with Q4 2006
*Excludes accumulated other comprehensive income (loss). See Appendix for corresponding GAAP measure.
50

Consolidated RBC Ratio*
CNO
Decrease primarily due to
increase in required capital
on CIG annuity block
*Risk-Based Capital (“RBC”) requirements provide a tool for insurance regulators to determine the levels of
statutory capital and surplus an insurer must maintain in relation to its insurance and investment risks. The RBC
ratio is the ratio of the statutory consolidated adjusted capital of our insurance subsidiaries to RBC.
51

Net Investment Income
CNO
($ millions)
Increase from Q4 2006 due to
increase in prepayment
income and higher portfolio
yield
Net investment income from the prepayment of securities:                         $1.2                  $5.3                 $0.5                  $1.0                 $5.0
General Account Investment Income,
Excluding Corporate Segment
5.83%
5.72%
5.72%
5.71%
5.64%
Yield:
52

High-Quality Assets
CNO
Portfolio quality remains high
and has not significantly
changed since year-end 2006
Actively Managed Fixed Maturities by Rating at
3/31/07 (Market Value)
3/31/07
93%
12/31/06
93%
9/30/06
95%
6/30/06
95%
3/31/06
95%
% of Bonds which are Investment Grade:
53

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of net income applicable to common stock to the net operating income, excluding Q2 2006 charge related to tentative litigation
settlement (and related per share amounts) is as follows (dollars in millions, except per share amounts):
54
Q1 06
Q2 06
Q3 06
Q4 06
Q1 07
Net income (loss) applicable to common stock
55.1
$   

(31.8)
$  

38.9
$   

(3.7)
$   

0.9
$     

Net realized investment losses, net of related
amortization and taxes
0.7

0.1

13.9

9.4

13.7

Net operating income (loss) (a non-GAAP
financial measure)
55.8

(31.7)

52.8

5.7

14.6

2Q2006 charge related to the tentative litigation
settlement, net of taxes
-

102.1

-

-

-

Net operating income before Q2 2006 charge related
to the tentative litigation settlement
(a non-GAAP financial measure)
55.8
$   

70.4
$   

52.8
$   

5.7
$     

14.6
$   

Per diluted share:
Net income (loss)
0.35
$   

(0.21)
$  

0.26
$   

(0.02)
$  

0.01
$   

Net realized investment losses, net of related
amortization and taxes
0.01

-

0.09

0.06

0.09

Net operating income (loss) (a non-GAAP
financial measure)
0.36

(0.21)

0.35

0.04

0.10

Q2 2006 charge related to the tentative litigation
settlement, net of taxes
-

0.67

-

-

-

Net operating income before Q2 2006 charge related
to the tentative litigation settlement
(a non-GAAP financial measure)
0.36
$   

0.46
$   

0.35
$   

0.04
$   

0.10
$   

Information Related to Certain Non-GAAP Financial Measures
Book value, excluding accumulated other comprehensive income, per diluted share 
This non-GAAP financial measure differs from book value per diluted share because accumulated other comprehensive income has been
excluded from the book value used to determine the measure.  Management believes this non-GAAP financial measure is useful because it
removes the volatility that arises from changes in accumulated other comprehensive income.  Such volatility is often caused by changes in the
estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made
by management.

55

Information Related to Certain Non-GAAP Financial Measures
A reconciliation from book value per diluted share to book value per diluted share, excluding accumulated other comprehensive income (loss) is
as follows (dollars in millions, except per share amounts):
56
Q1 06
Q2 06
Q3 06
Q4 06
Q1 07
Total shareholders' equity
4,283.3
$        

4,296.6
$        

4,712.7
$        

4,713.1
$        

4,724.0
$      

Less accumulated other comprehensive income (loss)
(224.2)

(445.6)

(71.8)

(72.6)

(41.8)

Total shareholders' equity excluding
accumulated other comprehensive income (loss)
(a non-GAAP financial measure)
4,507.5
$        

4,742.2
$        

4,784.5
$        

4,785.7
$        

4,765.8
$      

Diluted shares outstanding for the period
183,532,954

183,554,073

185,354,251

186,665,776

188,784,663

Book value per diluted share
23.34
$         

23.41
$         

25.43
$         

25.25
$         

25.02
$         

Less accumulated other comprehensive income (loss)
(1.22)

(2.43)

(0.38)

(0.39)

(0.22)

Book value, excluding accumulated other
comprehensive income (loss), per diluted share
(a non-GAAP financial measure)
24.56
$         

25.84
$         

25.81
$         

25.64
$         

25.24
$         

Information Related to Certain Non-GAAP Financial Measures
Operating return measures
Management believes that an analysis of return before net realized gains or losses (“net operating income”, a non-GAAP financial measure) is
important to evaluate the performance of the Company and is a key measure commonly used in the life insurance industry.  Management uses
this measure to evaluate performance because realized investment gains or losses can be affected by events that are unrelated to the
Company’s underlying fundamentals.  
In addition, our return for Q2 2006 was affected by an unusual and significant charge related to a tentative litigation settlement.  Management
does not believe that a similar charge is likely to recur within two years, and there were no similar charges recognized within the prior two years.  
Management believes an analysis of return before this charge is important to evaluate the performance of the Company prior to the effect of this
unusual and significant charge.
This non-GAAP financial measure also differs from return on equity because accumulated other comprehensive income (loss) has been excluded
from the value of equity used to determine this ratio.  Management believes this non-GAAP financial measure is useful because it removes the
volatility that arises from changes in accumulated other comprehensive income (loss).  Such volatility is often caused by changes in the
estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made
by management.
In addition, our equity includes the value of significant net operating loss carryforwards (included in income tax assets).  In accordance with  
GAAP, these assets are not discounted, and accordingly will not provide a return to shareholders (until after it is realized as a reduction to taxes
that would otherwise be paid).  Management believes that excluding this value from the equity component of this measure enhances the
understanding of the effect these non-discounted assets have on operating returns and the comparability of these measures from period-to-
period.  Equity in all periods assumes the conversion of our 5.5% Class B Mandatorily Convertible Preferred Stock (which will occur in May
2007).  In addition, the Company plans to change the way compensation for its executives is determined in the future.  Operating return
measures will be the primary manner of measuring the performance of our business units and will be used as a basis for incentive compensation.
All references to segment operating return measures assume a 25% debt to total capital ratio at the segment level.  Additionally, corporate
expenses have been allocated to the segments.
57

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of return on common equity to operating return (less Q2 2006 charge related to the tentative litigation settlement) on common
equity (excluding accumulated other comprehensive income (loss) and net operating loss carryforwards) is as follows (dollars in millions, except
per share amounts):
(continued on next page)
58
Q1 06
Q2 06
Q3 06
Q4 06
Q1 07
Net income (loss) applicable to common stock
55.1
$      

(31.8)
$      

38.9
$      

(3.7)
$      

0.9
$        

Net realized investment (gains) losses, net of related
amortization and taxes
0.7

0.1

13.9

9.4

13.7

Net operating income (loss) (a non-GAAP
financial measure)
55.8

(31.7)

52.8

5.7

14.6

Q2 2006 charge related to the tentative litigation
settlement, net of taxes
-

102.1

-

-

-

Add preferred stock dividends, assuming conversion
9.5

9.5

9.5

9.5

9.5

Net operating income before Q2 2006 charge related
to the tentative litigation settlement
(a non-GAAP financial measure)
65.3
$      

79.9
$      

62.3
$      

15.2
$      

24.1
$      

Total shareholders' equity
4,283.3
$  

4,296.6
$  

4,712.7
$  

4,713.1
$  

4,724.0
$  

Less preferred stock
667.8

667.8

667.8

667.8

667.8

Common shareholders' equity
3,615.5

3,628.8

4,044.9

4,045.3

4,056.2

Add preferred stock, assuming conversion
667.8

667.8

667.8

667.8

667.8

Less accumulated other comprehensive income (loss)
(224.2)

(445.6)

(71.8)

(72.6)

(41.8)

Common shareholder's equity, excluding accumulated
other comprehensive income (loss) (a non-GAAP
financial measure)
4,507.5

4,742.2

4,784.5

4,785.7

4,765.8

Less net operating loss carryforwards
1,112.1

1,346.6

1,346.7

1,340.0

1,334.1

Common shareholders' equity, excluding accumulated
other comprehensive income (loss) and net operating
loss carryforwards (a non-GAAP financial measure)
3,395.4
$  

3,395.6
$  

3,437.8
$  

3,445.7
$  

3,431.7
$  

Information Related to Certain Non-GAAP Financial Measures
(continued from previous page)
59
Q1 06
Q2 06
Q3 06
Q4 06
Q1 07
Average common shareholders' equity
3,733.8

3,622.2

3,836.9

4,045.1

4,050.8

Average common shareholder's equity, excluding accumulated
other comprehensive income (loss)
(a non-GAAP financial measure)
4,477.8

4,624.9

4,763.4

4,785.1

4,775.8

Average common shareholders' equity, excluding
accumulated other comprehensive income
(loss) and net operating loss carryforwards
(a non-GAAP financial measure)
3,362.6

3,395.5

3,416.7

3,441.8

3,438.7

Return on equity ratios:
Return on common equity
5.9%
-3.5%
4.1%
-0.4%
0.1%
Operating return (less Q2 2006 charge related to the
tentative litigation settlement) on
common equity, excluding accumulated
other comprehensive income (loss)
(a non-GAAP financial measure)
5.8%
6.9%
5.2%
1.3%
2.0%
Operating return (less Q2 2006 charge related to the
tentative litigation settlement) on common
equity, excluding accumulated other
comprehensive income (loss) and
net operating loss carryforwards
(a non-GAAP financial measure)
7.8%
9.4%
7.3%
1.8%
2.8%

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of pretax operating earnings (a non-GAAP financial measure) to segment operating income (loss) and consolidated net income
(loss) for the three months ended March 31, 2007, is as follows (dollars in millions):
(Continued on next page)
60
Other Business
CIG
Bankers
Colonial Penn
in Run-off
Corporate
Total
Pretax operating earnings (a non-GAAP financial measure)
51.5
$         

42.8
$           

4.6
$            

(30.9)
$           

(30.8)
$         

37.2
$         

Allocation of interest expense, excess capital and corporate
expenses
(16.2)

(13.4)

(1.0)

(2.9)

33.5

-

Income tax (expense) benefit
(12.5)

(10.4)

(1.3)

11.9

(0.8)

(13.1)

Segment operating income (loss)
22.8
$         

19.0
$           

2.3
$            

(21.9)
$           

1.9
$            

24.1

Net realized investment losses, net of related amortization and taxes
(13.7)

Net income
10.4
$         

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of common shareholders’ equity, excluding accumulated other comprehensive income (loss) and less income tax assets and
assuming conversion of the convertible preferred stock (a non-GAAP financial measure) to common shareholders’ equity is as follows (dollars in
millions):
(Continued on next page)
(Continued from previous page)
61
Other Business
CIG
Bankers
Colonial Penn
in Run-off
Corporate
Total
December 31, 2006
Common shareholders' equity, excluding accumulated
other comprehensive income (loss) and less income tax
assets representing net operating loss carryforwards
and assuming conversion of convertible preferred stock
(a non-GAAP financial measure)
1,546.5
$      

1,274.3
$      

103.6
$         

290.3
$         

231.0
$         

3,445.7
$      

Net operating loss carryforwards
1,340.0

-

-

-

-

1,340.0

Accumulated other comprehensive income (loss)
(25.6)

(41.6)

(1.2)

(7.3)

3.1

(72.6)

Allocation of capital
515.5

424.8

34.6

96.8

(1,071.7)

-

Total shareholders' equity
3,376.4
$      

1,657.5
$      

137.0
$         

379.8
$         

(837.6)
$        

4,713.1

Less preferred stock
667.8

Common shareholders' equity
4,045.3
$      

March 31, 2007
Common shareholders' equity, excluding accumulated
other comprehensive income (loss) and less income tax
assets representing net operating loss carryforwards
and assuming conversion of convertible preferred stock
(a non-GAAP financial measure)
1,568.1
$      

1,290.8
$      

105.7
$         

275.3
$         

191.8
$         

3,431.7
$      

Net operating loss carryforwards
1,334.1

1,334.1

Accumulated other comprehensive income (loss)
(8.1)

(30.7)

(0.2)

(7.8)

5.0

(41.8)

Allocation of capital
522.7

430.3

35.3

91.7

(1,080.0)

-

Total shareholders' equity
3,416.8
$      

1,690.4
$      

140.8
$         

359.2
$         

(883.2)
$        

4,724.0

Less preferred stock
667.8

Common shareholders' equity
4,056.2
$      

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of average common shareholders’ equity, excluding accumulated other comprehensive income (loss) and less income tax assets
and assuming conversion of the convertible preferred stock (a non-GAAP financial measure) to average common shareholders’ equity at March
31, 2007, is as follows (dollars in millions):
62
(Continued from previous page)
Other Business
CIG
Bankers
Colonial Penn
in Run-off
Corporate
Total
Average common shareholders' equity, excluding accumulated
other comprehensive income (loss) and less income tax
assets representing net operating loss carryforwards
and assuming conversion of convertible preferred stock
(a non-GAAP financial measure)
1,557.3
$      

1,282.6
$      

104.7
$         

282.8
$         

211.3
$         

3,438.7
$      

Average net operating loss carryforwards
1,337.1

Average accumulated other comprehensive income (loss)
(57.2)

Average total shareholders' equity
4,718.6

Average preferred stock
667.8

Average common shareholders' equity
4,050.8

Return on equity ratios:
Return on equity
1.0%
Operating return on equity, excluding accumulated other
comprehensive income (loss) and less income tax
assets representing net operating loss carryforwards
and assuming conversion of convertible preferred stock
(a non-GAAP financial measure)
5.9%
5.9%
8.7%
-31.1%
3.5%
2.8%

Information Related to Certain Non-GAAP Financial Measures
Debt to capital ratio, excluding accumulated other comprehensive income (loss)
This non-GAAP financial measure differs from the debt to capital ratio because accumulated other comprehensive income has been excluded
from the value of capital used to determine this measure.  Management believes this non-GAAP financial measure is useful because it removes
the volatility that arises from changes in accumulated other comprehensive income.  Such volatility is often caused by changes in the estimated
fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by
management.
  
63

Information Related to Certain Non-GAAP Financial Measures
A reconciliation of the debt to capital ratio to debt to capital, excluding accumulated other comprehensive income (loss), is as follows (dollars in
millions):
Q1 06
Q2 06
Q3 06
Q4 06
Q1 07
Corporate notes payable
805.3
$     

805.5
$     

805.6
$     

1,000.8
$   

999.3
$     

Total shareholders' equity
4,283.3

4,296.6

4,712.7

4,713.1

4,724.0

Total capital
5,088.6

5,102.1

5,518.3

5,713.9

5,723.3

Less accumulated other comprehensive income (loss)
224.2

445.6

71.8

72.6

41.8

Total capital, excluding accumulated other
comprehensive income (loss)
(a non-GAAP financial measure)
5,312.8
$   

5,547.7
$   

5,590.1
$   

5,786.5
$   

5,765.1
$  

Corporate notes payable to capital ratios:
Corporate debt to total capital
15.8%
15.8%
14.6%
17.5%
17.5%
Corporate debt to total capital, excluding accum-
ulated other comprehensive income (loss)
(a non-GAAP financial measure)
15.2%
14.5%
14.4%
17.3%
17.3%
64